Product Detail
Piribedil
Piribedil API
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
API
API Family
Piribedil
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Piribedil Product Information
Piribedil is listed under API. It is associated with Piribedil and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-40167.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Piribedil
CAS No.
3605-01-4
CAT No.
CS-T-40167
Molecular Formula
C₁₆H₁₈N₄O₂
Molecular Weight
298.34
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
C1(C=CC(CN2CCN(C3=NC=CC=N3)CC2)=C4)=C4OCO1
IUPAC Name
2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
Piribedil is an antiparkisonian agent that acts as a dopamine agonist. Piribedil also displays a2-adrenergic antagonist properties. Piribedil has also been shown to counteract age-related memory impairment by improving memory and attention as well as increasing the velocity of psychomotor reactions and lability of nervous processes.
Synonyms
1-(2-Pyrimidyl)-4-(3,4-methylenedioxybenzyl)piperazine;
1-(2-Pyrimidyl)-4-piperonylpiperazine
Application Notes
Piribedil is an antiparkisonian agent that acts as a dopamine agonist. Piribedil also displays a2-adrenergic antagonist properties. Piribedil has also been shown to counteract age-related memory impairment by improving memory and attention as well as increasing the velocity of psychomotor reactions and lability of nervous processes.
References
"Millan, M,J, et al,: J, Pharmacol, Exp, Therap,, 297, 876 (2001); Gobert, A, et al,: J, Pharmacol, Exp, Therap,, 305, 338 (2003); Bochkarev, V,K, et al,: Zh, Nevrol, Psikhiatr, Im, S,S, Korsakova, 105, 46 (2005);"
